Evidence Hub

Retraction statement: Role of resolvin D1 in psoriasis before and after narrowband ultraviolet B phototherapy: A case–control study

A. Halim

Dermatologic Therapy, 2021

Abstract

Retraction: Elmasry, MF, Hassan, E, Rashed, LA, Abdel Halim, DM. Role of resolvin D1 in psoriasis before and after narrowband ultraviolet B phototherapy: A case-control study. Dermatologic Therapy. 2021; 34:e14879 (https://doi.org/10.1111/dth.14879). The above article, published online on 14 February 2021 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal's Editor-in-Chief, Dr Robert Schwartz, and Wiley Periodicals, LLC. The retraction has been agreed due to errors within the methodology section. The authors previously indicated that resolvin D1 was measured using a PCR technique, when it was actually an ELISA test that was used. As a result, significant changes to the methodology section and corresponding updates to tables and figures are needed. Due to the number of changes needed, the journal is unable to determine the veracity of the authors' previously reported results and conclusions and so has taken the decision to retract the article.

How strong is the evidence?

Evidence Hub reads this as a case-control. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free